J. M. van der Zon

Suppression of intestinal mucosal natural killer cells by corticosteroids

H. Verspaget, G. Griffioen, C. Lamers, 1997, Alimentary pharmacology & therapeutics.

Tissue level, activation and cellular localisation of TGF-β1 and association with survival in gastric cancer patients

Cornelis F. M. Sier, J. Verheijen, H. Verspaget, 2007, British Journal of Cancer.

Active TGF-beta1 correlates with myofibroblasts and malignancy in the colorectal adenoma-carcinoma sequence.

D. Hommes, H. Verspaget, J. Verheijen, 2009, Cancer science.

Infliximab treatment influences the serological expression of matrix metalloproteinase (MMP)‐2 and ‐9 in Crohn's disease

H. Verspaget, Q. Gao, C. Lamers, 2007, Inflammatory bowel diseases.

Freedom from disease in psoriasis: a Delphi consensus definition by patients, nurses and physicians

A. Bewley, C. Paul, A. Egeberg, 2021, Journal of the European Academy of Dermatology and Venereology : JEADV.

In vitro cellular cytotoxicity in Crohn's disease and ulcerative colitis: relation with disease activity and treatment, and the effect of recombinant gamma-interferon.

H. Verspaget, C. Lamers, A. Peña, 1989, Journal of clinical & laboratory immunology.

Interaction with colon cancer cells hyperactivates TGF-β signaling in cancer-associated fibroblasts

W. Mesker, P. Dijke, J. Lindeman, 2014, Oncogene.